Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05484492 · ClinicalTrials.gov registry record · Phase 4
Alveolar Ridge Preservation With Putty Allograft vs. Putty Alloplast Graft
A Phase 4 study of Alveolar Bone Resorption, sponsored by University of Louisville.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05484492: Completed Phase 4 study of Alveolar Bone Resorption, sponsored by University of Louisville.
NCT05484492 is a Phase 4 study of Alveolar Bone Resorption that has completed, run by University of Louisville. The registered enrollment target is 30 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05484492, a Phase 4 study of Alveolar Bone Resorption, has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary aims of this study are to compare, after 4 months, the clinical and histologic results of a combination demineralized/mineralized putty allograft vs. synthetic calcium phosphosilicate (CPS) putty alloplast graft utilization in socket preservation procedures. A regenerative tissue matrix membrane will be used to cover each graft lying below the flap.
Primary Outcome
Alveolar ridge width (measured in mm) after 4 months of healing
Conditions Studied
Interventions
- BIOLOGICAL demineralized and mineralized combination putty bone allograft
- BIOLOGICAL calcium phosphosilicate putty alloplast graft
Study Locations (1)
Kentucky
- University of Louisville - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-10-06 |
| Est. Completion | 2025-10-30 |
| Phase | Phase 4 |
What the finished NCT05484492 record still lists
NCT05484492 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Alveolar Bone Resorption appearing as the primary indexed condition, and to 2 interventions - of which demineralized and mineralized combination putty bone allograft is the first listed.
NCT05484492 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT05484492 about?
NCT05484492 is a clinical study titled "Alveolar Ridge Preservation With Putty Allograft vs. Putty Alloplast Graft". The primary aims of this study are to compare, after 4 months, the clinical and histologic results of a combination demineralized/mineralized putty allograft vs. synthetic calcium phosphosilicate (CPS) putty alloplast graft utilization in socket preservation procedures. A regenerative tissue matrix ...
What is the current status of trial NCT05484492?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2022-10-06. Estimated completion is 2025-10-30.
What conditions does trial NCT05484492 study?
This clinical trial studies the following conditions: Alveolar Bone Resorption.
What interventions are being tested in trial NCT05484492?
The interventions under investigation include: demineralized and mineralized combination putty bone allograft (BIOLOGICAL), calcium phosphosilicate putty alloplast graft (BIOLOGICAL).
Who is sponsoring clinical trial NCT05484492?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05484492 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05484492's enrollment target sits among peer trials
30 1552nd of 2000 higher than 367 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI